Appropriate pre-transplant strategy for patients with myelodysplastic syndromes receiving allogeneic haematopoietic stem cell transplantation after myeloablative conditioning.

Front Immunol · 2023 · PMC10011085 · PMID 36926344

Europe PMC DOI

hedged sentence

0.0560

closest p · 1.1× alpha

0.0560

boldest claim

The sentences

showed a trendP=0.056so close (0.05 < p ≤ 0.1)

For RFS, patients with blast level of ≥15% showed a trend of worse RFS ( sFigure 6B , P=0.056).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.